{"id":7983,"date":"2026-06-30T08:22:51","date_gmt":"2026-06-30T06:22:51","guid":{"rendered":"https:\/\/www.metaltronica.com\/?p=7983"},"modified":"2026-06-29T09:25:19","modified_gmt":"2026-06-29T07:25:19","slug":"glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds","status":"publish","type":"post","link":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/","title":{"rendered":"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds"},"content":{"rendered":"<h2>Emerging research presented at the American Society of Clinical Oncology (ASCO) 2026 meeting suggests that GLP-1 receptor agonists\u2014commonly used for weight control, for managing blood sugar (glucose) levels in people with Type 2 diabetes, cardiovascular diseases, addiction and kidney and liver diseases\u2014may significantly lower breast cancer risk in women.<\/h2>\n<blockquote>\n<p class=\"p1\">An observational analysis of over 110,000 cases found that women using GLP-1 medications were 35% less likely to be diagnosed with breast cancer, highlighting a potential new benefit beyond metabolic health.<\/p>\n<\/blockquote>\n<h3 class=\"p1\">New findings presented at the 2026 annual meeting of the American Society of Clinical Oncology (ASCO) point to a promising potential benefit of GLP-1 receptor agonists: a reduced risk of breast cancer in women.<\/h3>\n<p class=\"p1\">The observational study, led by Elizabeth McDonald, MD, PhD, a professor of radiology at the University of Pennsylvania Perelman School of Medicine, analyzed data from more than 110,000 cases. Researchers found that women taking GLP-1 medications were approximately <b>35% less likely<\/b> to develop breast cancer compared to those not using these therapies.<\/p>\n<p class=\"p1\">GLP-1 drugs have already demonstrated benefits across various health conditions, including weight control, management of blood sugar (glucose) levels in people with Type 2 diabetes, cardiovascular diseases, addiction and kidney and liver diseases. However, their impact on cancer risk has remained relatively underexplored\u2014making these findings especially noteworthy.<\/p>\n<p class=\"p1\">The study, managed by the American College of Radiology (ACR), underscores a <b>potential link<\/b> between GLP-1 use and lower breast cancer incidence. While the results are encouraging, experts caution that the research is observational and does not establish a direct cause-and-effect relationship.<\/p>\n<p class=\"p1\">Etta D. Pisano, MD, FACR, Chief Research Officer at the ACR and a senior author of the study, emphasized the importance of further investigation. She noted that advancements in screening and treatment have already reduced breast cancer mortality by more than 40% over the past four decades, and preventive strategies could offer an even greater impact.<\/p>\n<p class=\"p1\">According to Pisano, the next step is conducting large-scale prospective studies to determine whether GLP-1 medications can play a role in <b>breast cancer prevention<\/b>. Such research could potentially reshape clinical approaches and public health strategies if a causal link is confirmed.<\/p>\n<p class=\"p1\">In response to these findings, ACR leaders are advocating for increased funding and expanded research efforts to better understand how GLP-1 therapies may influence cancer development.<\/p>\n<p class=\"p1\">As interest in GLP-1 medications continues to grow, this new data adds to a rapidly evolving body of evidence suggesting these drugs may offer benefits far beyond weight management\u2014potentially opening new avenues in oncology prevention.<\/p>\n<p class=\"p1\">Sources:<\/p>\n<p class=\"p2\"><span class=\"s1\"><a href=\"https:\/\/my.clevelandclinic.org\/health\/treatments\/13901-glp-1-agonists\">https:\/\/my.clevelandclinic.org\/health\/treatments\/13901-glp-1-agonists<\/a><\/span><\/p>\n<p class=\"p2\"><span class=\"s1\"><a href=\"https:\/\/radiologybusiness.com\/hannah-murphy\"><i>Hannah Murphy<\/i><\/a><\/span><span class=\"s2\"><i>\u00a0| June 01, 2026 |\u00a0<\/i><a href=\"https:\/\/radiologybusiness.com\/topics\/medical-imaging\/womens-imaging\/women-glp-1-medications-may-be-less-likely-develop-breast-cancer\"><span class=\"s3\"><i>Radiology Business<\/i><\/span><\/a><i>\u00a0|\u00a0<\/i><a href=\"https:\/\/radiologybusiness.com\/topics\/medical-imaging\/womens-imaging\"><span class=\"s3\"><i>Womens Imaging<\/i><\/span><\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Emerging research presented at the American Society of Clinical Oncology (ASCO) 2026 meeting suggests that GLP-1 receptor agonists\u2014commonly used for weight control, for managing blood sugar (glucose) levels [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7981,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[99,25],"tags":[],"class_list":["post-7983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-prevention","category-prevenzione"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds - Metaltronica Spa<\/title>\n<meta name=\"description\" content=\"New research reveals GLP-1 medications may reduce breast cancer risk in women by 35%. Learn how these weight loss drugs could impact cancer prevention.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds - Metaltronica Spa\" \/>\n<meta property=\"og:description\" content=\"New research reveals GLP-1 medications may reduce breast cancer risk in women by 35%. Learn how these weight loss drugs could impact cancer prevention.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/\" \/>\n<meta property=\"og:site_name\" content=\"Metaltronica Spa\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T06:22:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.metaltronica.com\/wp-content\/uploads\/2026\/06\/DIABETES-e-MAMMOHGRAFIA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"system_riva\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"system_riva\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/\"},\"author\":{\"name\":\"system_riva\",\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/#\\\/schema\\\/person\\\/60e50ed7a184dd11474498e2950cb848\"},\"headline\":\"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds\",\"datePublished\":\"2026-06-30T06:22:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/\"},\"wordCount\":437,\"image\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.metaltronica.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DIABETES-e-MAMMOHGRAFIA.jpg\",\"articleSection\":[\"Prevention\",\"Prevenzione\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/\",\"url\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/\",\"name\":\"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds - Metaltronica Spa\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.metaltronica.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DIABETES-e-MAMMOHGRAFIA.jpg\",\"datePublished\":\"2026-06-30T06:22:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/#\\\/schema\\\/person\\\/60e50ed7a184dd11474498e2950cb848\"},\"description\":\"New research reveals GLP-1 medications may reduce breast cancer risk in women by 35%. Learn how these weight loss drugs could impact cancer prevention.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.metaltronica.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DIABETES-e-MAMMOHGRAFIA.jpg\",\"contentUrl\":\"https:\\\/\\\/www.metaltronica.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/DIABETES-e-MAMMOHGRAFIA.jpg\",\"width\":2000,\"height\":1333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/2026\\\/06\\\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prevenzione\",\"item\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/category\\\/prevenzione\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/\",\"name\":\"Metaltronica\",\"description\":\"Metaltronica Spa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/#\\\/schema\\\/person\\\/60e50ed7a184dd11474498e2950cb848\",\"name\":\"system_riva\",\"sameAs\":[\"https:\\\/\\\/www.metaltronica.com\"],\"url\":\"https:\\\/\\\/www.metaltronica.com\\\/en\\\/author\\\/system_riva\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds - Metaltronica Spa","description":"New research reveals GLP-1 medications may reduce breast cancer risk in women by 35%. Learn how these weight loss drugs could impact cancer prevention.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/","og_locale":"en_US","og_type":"article","og_title":"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds - Metaltronica Spa","og_description":"New research reveals GLP-1 medications may reduce breast cancer risk in women by 35%. Learn how these weight loss drugs could impact cancer prevention.","og_url":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/","og_site_name":"Metaltronica Spa","article_published_time":"2026-06-30T06:22:51+00:00","og_image":[{"width":2000,"height":1333,"url":"https:\/\/www.metaltronica.com\/wp-content\/uploads\/2026\/06\/DIABETES-e-MAMMOHGRAFIA.jpg","type":"image\/jpeg"}],"author":"system_riva","twitter_card":"summary_large_image","twitter_misc":{"Written by":"system_riva","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/#article","isPartOf":{"@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/"},"author":{"name":"system_riva","@id":"https:\/\/www.metaltronica.com\/en\/#\/schema\/person\/60e50ed7a184dd11474498e2950cb848"},"headline":"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds","datePublished":"2026-06-30T06:22:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/"},"wordCount":437,"image":{"@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/www.metaltronica.com\/wp-content\/uploads\/2026\/06\/DIABETES-e-MAMMOHGRAFIA.jpg","articleSection":["Prevention","Prevenzione"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/","url":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/","name":"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds - Metaltronica Spa","isPartOf":{"@id":"https:\/\/www.metaltronica.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/#primaryimage"},"image":{"@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/www.metaltronica.com\/wp-content\/uploads\/2026\/06\/DIABETES-e-MAMMOHGRAFIA.jpg","datePublished":"2026-06-30T06:22:51+00:00","author":{"@id":"https:\/\/www.metaltronica.com\/en\/#\/schema\/person\/60e50ed7a184dd11474498e2950cb848"},"description":"New research reveals GLP-1 medications may reduce breast cancer risk in women by 35%. Learn how these weight loss drugs could impact cancer prevention.","breadcrumb":{"@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/#primaryimage","url":"https:\/\/www.metaltronica.com\/wp-content\/uploads\/2026\/06\/DIABETES-e-MAMMOHGRAFIA.jpg","contentUrl":"https:\/\/www.metaltronica.com\/wp-content\/uploads\/2026\/06\/DIABETES-e-MAMMOHGRAFIA.jpg","width":2000,"height":1333},{"@type":"BreadcrumbList","@id":"https:\/\/www.metaltronica.com\/en\/2026\/06\/glp-1-medications-linked-to-reduced-breast-cancer-risk-in-women-new-study-finds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.metaltronica.com\/en\/"},{"@type":"ListItem","position":2,"name":"Prevenzione","item":"https:\/\/www.metaltronica.com\/en\/category\/prevenzione\/"},{"@type":"ListItem","position":3,"name":"GLP-1 Medications Linked to Reduced Breast Cancer Risk in Women, New Study Finds"}]},{"@type":"WebSite","@id":"https:\/\/www.metaltronica.com\/en\/#website","url":"https:\/\/www.metaltronica.com\/en\/","name":"Metaltronica","description":"Metaltronica Spa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.metaltronica.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.metaltronica.com\/en\/#\/schema\/person\/60e50ed7a184dd11474498e2950cb848","name":"system_riva","sameAs":["https:\/\/www.metaltronica.com"],"url":"https:\/\/www.metaltronica.com\/en\/author\/system_riva\/"}]}},"_links":{"self":[{"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/posts\/7983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/comments?post=7983"}],"version-history":[{"count":1,"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/posts\/7983\/revisions"}],"predecessor-version":[{"id":7984,"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/posts\/7983\/revisions\/7984"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/media\/7981"}],"wp:attachment":[{"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/media?parent=7983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/categories?post=7983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.metaltronica.com\/en\/wp-json\/wp\/v2\/tags?post=7983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}